Location History:
- Monmouth Junction, NJ (US) (1997)
- New York, NY (US) (2001)
Company Filing History:
3 out of 1,567 
1 out of 299 Years Active: 1997-2001
Title: Innovator Spotlight: Mira A. Kanzelberger
Introduction
Mira A. Kanzelberger is a notable inventor hailing from Monmouth Junction, NJ, USA. With a focus on advancements in pharmacological compounds, her innovative contributions have led to the issuance of three patents. Her work is significant in the field of dopamine receptor research and anxiolytic development.
Latest Patents
Among her recent patents, Mira has developed compounds including 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists, which offer unique dopaminegic activity. Furthermore, she has contributed to the creation of bicyclic carboxamides that serve as 5-HT1A binding agents. These compounds, particularly 5-HT1A antagonists, are highlighted for their potential use as anxiolytics, showcasing her impact on therapeutic innovations.
Career Highlights
Mira has had a distinguished career, working for esteemed companies such as American Home Products Corporation and John Wyeth & Brother Limited. Her expertise in pharmacology and drug development has enabled her to make significant strides in scientific research and innovation.
Collaborations
Throughout her career, Mira has collaborated with noteworthy colleagues, including James Albert Nelson and Ian A. Cliffe. These partnerships have fostered an environment of productive research and development, further enhancing her contributions to the field.
Conclusion
In summary, Mira A. Kanzelberger stands out as a pioneering inventor whose work is driving advancements in pharmacological therapies. Her innovative patents underscore her commitment to improving healthcare and demonstrate the vital role of inventors in the advancement of science and medicine.